Next Article in Journal
The Fra-1/AP-1 Oncoprotein: From the “Undruggable” Transcription Factor to Therapeutic Targeting
Next Article in Special Issue
Clinical Evaluation of Nuclear Imaging Agents in Breast Cancer
Previous Article in Journal
Orchestrating Treatment Modalities in Metastatic Pancreatic Neuroendocrine Tumors—Need for a Conductor
Previous Article in Special Issue
Radioimmunotherapy in Oncology: Overview of the Last Decade Clinical Trials
 
 
Article

Article Versions Notes

Cancers 2022, 14(6), 1479; https://doi.org/10.3390/cancers14061479
Action Date Notes Link
article html file updated 1 August 2022 05:33 CEST Update https://www.mdpi.com/2072-6694/14/6/1479/html
article html file updated 14 March 2022 10:53 CET Update -
article pdf uploaded. 14 March 2022 10:51 CET Updated version of record https://www.mdpi.com/2072-6694/14/6/1479/pdf
article xml uploaded. 14 March 2022 10:51 CET Update https://www.mdpi.com/2072-6694/14/6/1479/xml
article xml file uploaded 14 March 2022 10:51 CET Update -
article html file updated 14 March 2022 10:39 CET Original file -
article pdf uploaded. 14 March 2022 10:38 CET Version of Record -
article xml uploaded. 14 March 2022 10:38 CET Update -
article xml file uploaded 14 March 2022 10:38 CET Original file -
Back to TopTop